(Q28087569)

title

Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine (English)

1 reference

main subject

personalized medicine

1 reference

inferred from title

hepatocellular carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Irene Bargellini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Valentina Battaglia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Davide Caramella

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Leonard Berliner

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Heinz U Lemke

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Eric vanSonnenberg

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hani Ashamalla

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

David Dosik

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hesham Hazin

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Syed Shah

8

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Smruti Mohanty

9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sid Verma

10

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Giuseppe Esposito

11

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Carlo Bartolozzi

15

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Paul Morrison

16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

23 September 2014

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 June 2020

copyright license

start time

23 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Management of hepatocellular carcinoma: An update

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

20 March 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Sorafenib in advanced hepatocellular carcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Prognosis of hepatocellular carcinoma: the BCLC staging classification

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Viral hepatocarcinogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

National Institutes of Health consensus development conference statement: management of hepatitis B.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Treatment failure in hepatitis C: mechanisms of non-response.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Randomized controlled trial of screening for hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Natural history and prognosis of hepatitis B.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Dysplastic nodules and hepatocarcinogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4274760

Information and communication technology in personalized medicine: a clinical use-case for hepatocellular cancer

2 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Alphafetoprotein: an obituary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-16

Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions

21 January 2018

1 reference

12 December 2020

Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging

1 reference

12 December 2020

Complications of microwave ablation for liver tumors: results of a multicenter study.

1 reference

12 December 2020

Improved survival with screening for hepatocellular carcinoma

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

12 December 2020

Identifiers

DOI

10.1186/1878-5085-5-16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 June 2020

1005321918

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

25538797

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25538797%20AND%20SRC:MED&resulttype=core&format=json